Edition:
United States

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

46.20USD
18 Jan 2019
Change (% chg)

$0.78 (+1.72%)
Prev Close
$45.42
Open
$45.58
Day's High
$46.64
Day's Low
$45.14
Volume
670,626
Avg. Vol
843,680
52-wk High
$111.36
52-wk Low
$29.26

Select another date:

UPDATE 2-Bristol-Myers cancer ruling hits shares after strong earnings

NEW YORK, July 26 Bristol-Myers Squibb Co on Thursday said European regulators plan to recommend against approving its immunotherapy combination as an initial treatment for kidney cancer, sending shares lower even after the U.S. drugmaker reported better-than-expected quarterly profit and raised its full-year forecast.

Bristol-Myers Q2 earnings rise, full-year forecast up on strong sales

NEW YORK, July 26 Bristol-Myers Squibb Co on Thursday posted better-than-expected second-quarter earnings and raised its full-year forecast on strong sales from its blockbuster cancer drug Opdivo and blood thinner Eliquis.

Select another date: